Novel Biodegradable Stents for Benign Esophageal Strictures Following Endoscopic Submucosal Dissection

2007 ◽  
Vol 53 (2) ◽  
pp. 330-333 ◽  
Author(s):  
Yasuharu Saito ◽  
Toyohiko Tanaka ◽  
Akira Andoh ◽  
Hideki Minematsu ◽  
Kazunori Hata ◽  
...  
2016 ◽  
Vol 04 (07) ◽  
pp. E794-E794
Author(s):  
Georgios Mavrogenis ◽  
Tom Moreels ◽  
Jean-Baptiste Chevaux ◽  
Maximilien Thoma ◽  
Pierre Deprez ◽  
...  

2011 ◽  
Vol 43 (2) ◽  
pp. 324-328 ◽  
Author(s):  
Yosuke Mochizuki ◽  
Yasuharu Saito ◽  
Toyohiko Tanaka ◽  
Norihisa Nitta ◽  
Hirokazu Yamada ◽  
...  

Author(s):  
Enrique Pérez-Cuadrado Robles ◽  
Tom G. Moreels ◽  
Hubert Piessevaux ◽  
Ralph Yeung ◽  
Tarik Aouattah ◽  
...  

Endoscopy ◽  
2016 ◽  
Vol 48 (10) ◽  
pp. 951-951
Author(s):  
Georgios Mavrogenis ◽  
Tom Moreels ◽  
Jean-Baptiste Chevaux ◽  
Maximilien Thoma ◽  
Pierre Deprez ◽  
...  

2020 ◽  
Vol 8 (3) ◽  
pp. 135-145
Author(s):  
Yue Zhang ◽  
Baozhen Zhang ◽  
Yidan Wang ◽  
Jingjing Zhang ◽  
Yufan Wu ◽  
...  

AbstractEndoscopic submucosal dissection (ESD) has become the main treatment for early esophageal cancer. While treating the disease, ESD may also cause postoperative esophageal stricture, which is a global issue that needs resolution. Various methods have been applied to resolve the problem, such as mechanical dilatation, glucocorticoids, anti-scarring drugs, and regenerative medicine; however, no standard treatment regimen exists. This article describes and evaluates the strengths and limitations of new and promising potential strategies for the treatment and prevention of esophageal strictures.


2018 ◽  
Vol 2018 ◽  
pp. 1-8 ◽  
Author(s):  
Peina Shi ◽  
Xiaoyun Ding

Endoscopic submucosal dissection (ESD) has been widely accepted as an effective, minimally invasive treatment for superficial esophageal cancers. However, esophageal stricture often occurs in patients with large mucosal defects after ESD. In this review, we discuss various approaches recently researched to prevent esophageal strictures after ESD. These approaches can be classified as pharmacological treatments, esophageal stent treatments, and tissue engineering approaches. Most of the preventive approaches still have their limitations and require further research. With the improvement of current therapies, ESD can be more widely utilized as a minimally invasive treatment with minimal complications.


Sign in / Sign up

Export Citation Format

Share Document